

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.07190204 |
| 2 | diacylglycerol metabolic process (GO:0046339) | 5.87914816 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51907849 |
| 4 | fatty acid transmembrane transport (GO:1902001) | 5.43302525 |
| 5 | fatty acid beta-oxidation (GO:0006635) | 5.38535107 |
| 6 | carnitine shuttle (GO:0006853) | 5.31299359 |
| 7 | biotin metabolic process (GO:0006768) | 5.28793326 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 5.13205813 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.13205813 |
| 10 | transcytosis (GO:0045056) | 5.09344459 |
| 11 | regulation of triglyceride catabolic process (GO:0010896) | 5.07927256 |
| 12 | acetyl-CoA metabolic process (GO:0006084) | 4.97012196 |
| 13 | valine metabolic process (GO:0006573) | 4.96143898 |
| 14 | lysine metabolic process (GO:0006553) | 4.95960626 |
| 15 | lysine catabolic process (GO:0006554) | 4.95960626 |
| 16 | lipid storage (GO:0019915) | 4.95154099 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.95026773 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.95026773 |
| 19 | fatty acid oxidation (GO:0019395) | 4.91242078 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 4.89709419 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.88558461 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85503062 |
| 23 | fatty acid catabolic process (GO:0009062) | 4.84619148 |
| 24 | lipid oxidation (GO:0034440) | 4.82464943 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.76439555 |
| 26 | triglyceride catabolic process (GO:0019433) | 4.68429755 |
| 27 | oxaloacetate metabolic process (GO:0006107) | 4.68140197 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 4.63412440 |
| 29 | acylglycerol catabolic process (GO:0046464) | 4.51028347 |
| 30 | neutral lipid catabolic process (GO:0046461) | 4.51028347 |
| 31 | branched-chain amino acid catabolic process (GO:0009083) | 4.49459357 |
| 32 | lipid particle organization (GO:0034389) | 4.47250723 |
| 33 | short-chain fatty acid metabolic process (GO:0046459) | 4.43221539 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 4.36780919 |
| 35 | positive regulation of lipid storage (GO:0010884) | 4.36103863 |
| 36 | regulation of fatty acid oxidation (GO:0046320) | 4.32576785 |
| 37 | positive regulation of lipid catabolic process (GO:0050996) | 4.31093720 |
| 38 | branched-chain amino acid metabolic process (GO:0009081) | 4.29726195 |
| 39 | carnitine transmembrane transport (GO:1902603) | 4.29399508 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.28549830 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 4.27935577 |
| 42 | monocarboxylic acid catabolic process (GO:0072329) | 4.27883290 |
| 43 | acyl-CoA biosynthetic process (GO:0071616) | 4.26596451 |
| 44 | thioester biosynthetic process (GO:0035384) | 4.26596451 |
| 45 | carnitine transport (GO:0015879) | 4.24743361 |
| 46 | amino-acid betaine transport (GO:0015838) | 4.24743361 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.20049309 |
| 48 | response to dietary excess (GO:0002021) | 4.17831894 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.14282223 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.14282223 |
| 51 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.11865560 |
| 52 | glyoxylate metabolic process (GO:0046487) | 4.11551050 |
| 53 | cysteine metabolic process (GO:0006534) | 4.09550633 |
| 54 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.08556640 |
| 55 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.08556640 |
| 56 | creatine metabolic process (GO:0006600) | 4.07580991 |
| 57 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.03293797 |
| 58 | ethanol metabolic process (GO:0006067) | 3.98758918 |
| 59 | carnitine metabolic process (GO:0009437) | 3.98089993 |
| 60 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.97716209 |
| 61 | polyol transport (GO:0015791) | 3.94737561 |
| 62 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.93653157 |
| 63 | tricarboxylic acid cycle (GO:0006099) | 3.93382247 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92807703 |
| 65 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.92583930 |
| 66 | white fat cell differentiation (GO:0050872) | 3.91940083 |
| 67 | bile acid biosynthetic process (GO:0006699) | 3.90509897 |
| 68 | cellular response to epinephrine stimulus (GO:0071872) | 3.88451874 |
| 69 | complement activation, alternative pathway (GO:0006957) | 3.87967604 |
| 70 | tricarboxylic acid metabolic process (GO:0072350) | 3.84117753 |
| 71 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.81769461 |
| 72 | positive regulation of cholesterol efflux (GO:0010875) | 3.79504796 |
| 73 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.79124072 |
| 74 | urea cycle (GO:0000050) | 3.78748248 |
| 75 | urea metabolic process (GO:0019627) | 3.78748248 |
| 76 | brown fat cell differentiation (GO:0050873) | 3.76934144 |
| 77 | primary alcohol metabolic process (GO:0034308) | 3.75367707 |
| 78 | response to phenylpropanoid (GO:0080184) | 3.75280884 |
| 79 | thioester metabolic process (GO:0035383) | 3.71779101 |
| 80 | acyl-CoA metabolic process (GO:0006637) | 3.71779101 |
| 81 | glycerol metabolic process (GO:0006071) | 3.71505653 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 3.70021083 |
| 83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.69135409 |
| 84 | protein heterotrimerization (GO:0070208) | 3.68152817 |
| 85 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.65764388 |
| 86 | * triglyceride biosynthetic process (GO:0019432) | 3.65180703 |
| 87 | regulation of cholesterol storage (GO:0010885) | 3.63745215 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 3.63391241 |
| 89 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.63036674 |
| 90 | quaternary ammonium group transport (GO:0015697) | 3.62934221 |
| 91 | succinate metabolic process (GO:0006105) | 3.62240546 |
| 92 | positive regulation of glomerulus development (GO:0090193) | 3.62068795 |
| 93 | organic acid catabolic process (GO:0016054) | 3.61996118 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.61996118 |
| 95 | negative regulation of granulocyte differentiation (GO:0030853) | 3.61205620 |
| 96 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.60953385 |
| 97 | homocysteine metabolic process (GO:0050667) | 3.56747403 |
| 98 | * acylglycerol biosynthetic process (GO:0046463) | 3.56305041 |
| 99 | * neutral lipid biosynthetic process (GO:0046460) | 3.56305041 |
| 100 | regulation of triglyceride metabolic process (GO:0090207) | 3.55505906 |
| 101 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.55484578 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.55309221 |
| 103 | indolalkylamine catabolic process (GO:0046218) | 3.54913089 |
| 104 | tryptophan catabolic process (GO:0006569) | 3.54913089 |
| 105 | indole-containing compound catabolic process (GO:0042436) | 3.54913089 |
| 106 | serine family amino acid catabolic process (GO:0009071) | 3.54407128 |
| 107 | * triglyceride metabolic process (GO:0006641) | 3.54301352 |
| 108 | kynurenine metabolic process (GO:0070189) | 3.53675909 |
| 109 | nitrogen cycle metabolic process (GO:0071941) | 3.52888873 |
| 110 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.52313782 |
| 111 | alpha-amino acid catabolic process (GO:1901606) | 3.49319220 |
| 112 | ethanol oxidation (GO:0006069) | 3.46901346 |
| 113 | glycogen catabolic process (GO:0005980) | 3.46218805 |
| 114 | cellular amino acid catabolic process (GO:0009063) | 3.44958215 |
| 115 | positive regulation of cholesterol transport (GO:0032376) | 3.43763320 |
| 116 | positive regulation of sterol transport (GO:0032373) | 3.43763320 |
| 117 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.43619017 |
| 118 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.42819826 |
| 119 | bile acid metabolic process (GO:0008206) | 3.41327916 |
| 120 | response to epinephrine (GO:0071871) | 3.40481186 |
| 121 | regulation of lipoprotein metabolic process (GO:0050746) | 3.39738588 |
| 122 | glucan catabolic process (GO:0009251) | 3.39033474 |
| 123 | regulation of cholesterol metabolic process (GO:0090181) | 3.39028231 |
| 124 | glycerolipid catabolic process (GO:0046503) | 3.38176698 |
| 125 | high-density lipoprotein particle remodeling (GO:0034375) | 3.37030179 |
| 126 | * acylglycerol metabolic process (GO:0006639) | 3.35263269 |
| 127 | tryptophan metabolic process (GO:0006568) | 3.35210376 |
| 128 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.35035214 |
| 129 | cGMP-mediated signaling (GO:0019934) | 3.33801153 |
| 130 | fructose metabolic process (GO:0006000) | 3.30768900 |
| 131 | * neutral lipid metabolic process (GO:0006638) | 3.30693995 |
| 132 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.30228757 |
| 133 | coenzyme catabolic process (GO:0009109) | 3.29046742 |
| 134 | coenzyme A metabolic process (GO:0015936) | 3.28560856 |
| 135 | fatty acid homeostasis (GO:0055089) | 3.27650751 |
| 136 | alditol metabolic process (GO:0019400) | 3.27413169 |
| 137 | coenzyme A biosynthetic process (GO:0015937) | 3.26060542 |
| 138 | retinol metabolic process (GO:0042572) | 3.25710640 |
| 139 | phospholipid homeostasis (GO:0055091) | 3.24477014 |
| 140 | ovulation from ovarian follicle (GO:0001542) | 3.18741953 |
| 141 | * NADH metabolic process (GO:0006734) | 3.16149866 |
| 142 | cellular polysaccharide catabolic process (GO:0044247) | 3.15630525 |
| 143 | regulation of lipid storage (GO:0010883) | 3.13324922 |
| 144 | negative regulation of macrophage differentiation (GO:0045650) | 3.11809689 |
| 145 | muscle filament sliding (GO:0030049) | 3.11780169 |
| 146 | actin-myosin filament sliding (GO:0033275) | 3.11780169 |
| 147 | positive regulation of glucose import (GO:0046326) | 3.09651774 |
| 148 | lipoprotein transport (GO:0042953) | 3.08283592 |
| 149 | negative regulation of protein autophosphorylation (GO:0031953) | 3.01356459 |
| 150 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.00643375 |
| 151 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.99690935 |
| 152 | regulation of cholesterol transport (GO:0032374) | 2.98579648 |
| 153 | regulation of sterol transport (GO:0032371) | 2.98579648 |
| 154 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.92758515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.30066287 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17066718 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.36114618 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.00303906 |
| 5 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.65123350 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.93832289 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.82668517 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41137739 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.95550123 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.87583134 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.12148379 |
| 12 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.0014759 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.83825883 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74345463 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54720889 |
| 16 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53098189 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51854916 |
| 18 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45022393 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38279567 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34952840 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29610798 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29609084 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28430652 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27764410 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22664264 |
| 26 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.22567382 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20510543 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20461917 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18862677 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16382348 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15781039 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15269270 |
| 33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14042464 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10462540 |
| 35 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.10138360 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07145643 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06111114 |
| 38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05741548 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05693616 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05328507 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05328507 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03374310 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03245385 |
| 44 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.02096955 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.98322895 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96198149 |
| 47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94657332 |
| 48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94657332 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93933655 |
| 50 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91249472 |
| 51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90819408 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89893154 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89250976 |
| 54 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.89234701 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88517529 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88517529 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87687770 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86960372 |
| 59 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86020693 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85364105 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85031972 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84962740 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84172362 |
| 64 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83865897 |
| 65 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83722952 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83505149 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83303954 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81614669 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81016562 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80885335 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79279684 |
| 72 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77041605 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76126083 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75890225 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75833895 |
| 76 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74703769 |
| 77 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73938742 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73778021 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73633872 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73071032 |
| 81 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.72266629 |
| 82 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.71755860 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.70698850 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 0.70397742 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69115703 |
| 86 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68913388 |
| 87 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.68709520 |
| 88 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68669698 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68171600 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68036546 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.67795646 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.67514493 |
| 93 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.67233711 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.66470323 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.66251864 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65903528 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.65876397 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65621644 |
| 99 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65397354 |
| 100 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64835344 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64582970 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63384655 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62768070 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62699019 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61589569 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60752317 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58721934 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58129681 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56915036 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56762715 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56598456 |
| 112 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.56132610 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56130012 |
| 114 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55502881 |
| 115 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.55398438 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.54887263 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54399959 |
| 118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53823822 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.52977632 |
| 120 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.51818257 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.51544216 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50745922 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50097756 |
| 124 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.49626946 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49087226 |
| 126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.48844259 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.48844016 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.48844016 |
| 129 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.48617480 |
| 130 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.48274099 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.47796389 |
| 132 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.47248177 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47136981 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46654856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.97856899 |
| 2 | MP0005360_urolithiasis | 5.67812002 |
| 3 | MP0005670_abnormal_white_adipose | 4.84476609 |
| 4 | MP0005365_abnormal_bile_salt | 4.57127358 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.12701469 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.70902803 |
| 7 | MP0004130_abnormal_muscle_cell | 3.52086788 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.49999303 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.08745121 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.83305499 |
| 11 | MP0005332_abnormal_amino_acid | 2.73373992 |
| 12 | MP0002971_abnormal_brown_adipose | 2.71346173 |
| 13 | MP0003252_abnormal_bile_duct | 2.65442733 |
| 14 | MP0002118_abnormal_lipid_homeostasis | 2.62166893 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.52131169 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.47815733 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.38179596 |
| 18 | MP0009840_abnormal_foam_cell | 2.25514539 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.25480137 |
| 20 | MP0000609_abnormal_liver_physiology | 2.07824292 |
| 21 | MP0004145_abnormal_muscle_electrophysio | 2.07078355 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.00330815 |
| 23 | MP0003195_calcinosis | 1.97870095 |
| 24 | MP0005535_abnormal_body_temperature | 1.92152984 |
| 25 | MP0003828_pulmonary_edema | 1.81545234 |
| 26 | MP0005334_abnormal_fat_pad | 1.77046698 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.75101932 |
| 28 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.73864324 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.73404434 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.64400247 |
| 31 | MP0005083_abnormal_biliary_tract | 1.58275493 |
| 32 | MP0009115_abnormal_fat_cell | 1.57702809 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.57023890 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.56954086 |
| 35 | MP0003646_muscle_fatigue | 1.56076415 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.50052207 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.47271352 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.47086933 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.44057822 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.43392493 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.42309935 |
| 42 | MP0002970_abnormal_white_adipose | 1.38849787 |
| 43 | MP0003186_abnormal_redox_activity | 1.38523285 |
| 44 | MP0001661_extended_life_span | 1.38052717 |
| 45 | MP0005448_abnormal_energy_balance | 1.34169765 |
| 46 | MP0002106_abnormal_muscle_physiology | 1.31605981 |
| 47 | MP0001764_abnormal_homeostasis | 1.31595473 |
| 48 | MP0003690_abnormal_glial_cell | 1.31225464 |
| 49 | MP0005369_muscle_phenotype | 1.28968626 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.25092787 |
| 51 | MP0004043_abnormal_pH_regulation | 1.24306650 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.22332928 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.21531222 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.19242859 |
| 55 | MP0000343_altered_response_to | 1.14196586 |
| 56 | MP0002972_abnormal_cardiac_muscle | 1.13915151 |
| 57 | MP0005503_abnormal_tendon_morphology | 1.11817986 |
| 58 | MP0003959_abnormal_lean_body | 1.04832499 |
| 59 | MP0000604_amyloidosis | 1.03098927 |
| 60 | MP0000750_abnormal_muscle_regeneration | 1.02518065 |
| 61 | MP0003329_amyloid_beta_deposits | 0.98354535 |
| 62 | MP0001756_abnormal_urination | 0.96643478 |
| 63 | MP0003011_delayed_dark_adaptation | 0.96276495 |
| 64 | MP0005451_abnormal_body_composition | 0.95375580 |
| 65 | MP0005452_abnormal_adipose_tissue | 0.94857594 |
| 66 | MP0002254_reproductive_system_inflammat | 0.91215821 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.90095504 |
| 68 | MP0003948_abnormal_gas_homeostasis | 0.88483151 |
| 69 | MP0005275_abnormal_skin_tensile | 0.87508551 |
| 70 | MP0005330_cardiomyopathy | 0.87426547 |
| 71 | MP0003879_abnormal_hair_cell | 0.86204706 |
| 72 | MP0000598_abnormal_liver_morphology | 0.85872879 |
| 73 | MP0008961_abnormal_basal_metabolism | 0.85152674 |
| 74 | MP0003724_increased_susceptibility_to | 0.83693914 |
| 75 | MP0000249_abnormal_blood_vessel | 0.83245958 |
| 76 | MP0005595_abnormal_vascular_smooth | 0.83182957 |
| 77 | MP0001881_abnormal_mammary_gland | 0.80902577 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.80194155 |
| 79 | MP0003868_abnormal_feces_composition | 0.78273354 |
| 80 | MP0010630_abnormal_cardiac_muscle | 0.77979971 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.77413419 |
| 82 | MP0003953_abnormal_hormone_level | 0.77359958 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.76946515 |
| 84 | MP0004087_abnormal_muscle_fiber | 0.76576690 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.76561779 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.75872973 |
| 87 | MP0000733_abnormal_muscle_development | 0.74223231 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.73431015 |
| 89 | MP0006138_congestive_heart_failure | 0.73355182 |
| 90 | MP0000751_myopathy | 0.73312259 |
| 91 | MP0004147_increased_porphyrin_level | 0.73285932 |
| 92 | MP0002796_impaired_skin_barrier | 0.73123830 |
| 93 | MP0009763_increased_sensitivity_to | 0.73072223 |
| 94 | MP0005266_abnormal_metabolism | 0.72918968 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.71282810 |
| 96 | MP0005647_abnormal_sex_gland | 0.71076697 |
| 97 | MP0004484_altered_response_of | 0.70991448 |
| 98 | MP0005620_abnormal_muscle_contractility | 0.70579026 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.70489188 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70401436 |
| 101 | MP0001501_abnormal_sleep_pattern | 0.70150002 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.69493486 |
| 103 | MP0000747_muscle_weakness | 0.67788331 |
| 104 | MP0003279_aneurysm | 0.67435482 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.67189071 |
| 106 | MP0002269_muscular_atrophy | 0.67000250 |
| 107 | MP0000749_muscle_degeneration | 0.65338665 |
| 108 | MP0005164_abnormal_response_to | 0.61859556 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.59367975 |
| 110 | MP0002933_joint_inflammation | 0.59212353 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.59140265 |
| 112 | MP0001544_abnormal_cardiovascular_syste | 0.59052408 |
| 113 | MP0005385_cardiovascular_system_phenoty | 0.59052408 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.58729212 |
| 115 | MP0008872_abnormal_physiological_respon | 0.58538048 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.58268260 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.57221261 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.54690734 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.54687333 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.54423379 |
| 121 | MP0004036_abnormal_muscle_relaxation | 0.53683679 |
| 122 | MP0009764_decreased_sensitivity_to | 0.52807510 |
| 123 | MP0002822_catalepsy | 0.52481007 |
| 124 | MP0002168_other_aberrant_phenotype | 0.52063716 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.51821340 |
| 126 | MP0003075_altered_response_to | 0.51395828 |
| 127 | MP0008469_abnormal_protein_level | 0.51326408 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.51310586 |
| 129 | MP0009672_abnormal_birth_weight | 0.51272509 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.50370848 |
| 131 | MP0004272_abnormal_basement_membrane | 0.50334553 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.49779763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 6.03255536 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.71820275 |
| 3 | Nemaline bodies (HP:0003798) | 5.60377494 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.40201506 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 5.38931635 |
| 6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.38931635 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.09318229 |
| 8 | Increased variability in muscle fiber diameter (HP:0003557) | 4.95893685 |
| 9 | Hypoglycemic coma (HP:0001325) | 4.91329377 |
| 10 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.85939641 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.85349575 |
| 12 | Xanthomatosis (HP:0000991) | 4.78780231 |
| 13 | Hyperammonemia (HP:0001987) | 4.73777634 |
| 14 | Ketosis (HP:0001946) | 4.67531290 |
| 15 | Hyperglycinemia (HP:0002154) | 4.45681412 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.30775916 |
| 17 | Myoglobinuria (HP:0002913) | 4.29579499 |
| 18 | Muscle fiber splitting (HP:0003555) | 4.22979576 |
| 19 | Ketoacidosis (HP:0001993) | 4.22103913 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 4.17092031 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 4.15423189 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 4.08474480 |
| 23 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.08474480 |
| 24 | Deep venous thrombosis (HP:0002625) | 4.06348174 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.05016370 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.02356555 |
| 27 | Complement deficiency (HP:0004431) | 3.91144429 |
| 28 | Neck muscle weakness (HP:0000467) | 3.86148756 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.85908277 |
| 30 | Epidermoid cyst (HP:0200040) | 3.81938545 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.56255805 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.56249821 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.54168217 |
| 34 | Oligomenorrhea (HP:0000876) | 3.53617336 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 3.51982102 |
| 36 | Hydroxyprolinuria (HP:0003080) | 3.48759017 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 3.48759017 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 3.47775180 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.43664417 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 3.39684868 |
| 41 | Frequent falls (HP:0002359) | 3.29683829 |
| 42 | Generalized aminoaciduria (HP:0002909) | 3.29538386 |
| 43 | Myopathic facies (HP:0002058) | 3.19680542 |
| 44 | EMG: myopathic abnormalities (HP:0003458) | 3.19453339 |
| 45 | Hypertriglyceridemia (HP:0002155) | 3.17799730 |
| 46 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.13618716 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 3.11201714 |
| 48 | Spinal rigidity (HP:0003306) | 3.09927120 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 3.06542898 |
| 50 | Rimmed vacuoles (HP:0003805) | 3.05847684 |
| 51 | Distal arthrogryposis (HP:0005684) | 3.04851125 |
| 52 | Increased muscle lipid content (HP:0009058) | 3.01662373 |
| 53 | Metabolic acidosis (HP:0001942) | 2.98304591 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.96477710 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.93733771 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.93042763 |
| 57 | Lethargy (HP:0001254) | 2.93007441 |
| 58 | Round ear (HP:0100830) | 2.92415940 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.91551250 |
| 60 | Acanthosis nigricans (HP:0000956) | 2.91516575 |
| 61 | Myotonia (HP:0002486) | 2.76991587 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.75171112 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.75142985 |
| 64 | Nausea (HP:0002018) | 2.74818396 |
| 65 | Cerebral edema (HP:0002181) | 2.73533875 |
| 66 | Hepatic necrosis (HP:0002605) | 2.69416027 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.67659280 |
| 68 | Calf muscle hypertrophy (HP:0008981) | 2.67077653 |
| 69 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67071336 |
| 70 | Abnormality of complement system (HP:0005339) | 2.66618129 |
| 71 | Gowers sign (HP:0003391) | 2.60684402 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.57122991 |
| 73 | Vomiting (HP:0002013) | 2.56956217 |
| 74 | Lipoatrophy (HP:0100578) | 2.54973256 |
| 75 | Skin nodule (HP:0200036) | 2.53206138 |
| 76 | Back pain (HP:0003418) | 2.51913749 |
| 77 | Gout (HP:0001997) | 2.49644799 |
| 78 | Increased purine levels (HP:0004368) | 2.47217521 |
| 79 | Hyperuricemia (HP:0002149) | 2.47217521 |
| 80 | Ulnar deviation of the wrist (HP:0003049) | 2.45898084 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 2.45429202 |
| 82 | Pancreatitis (HP:0001733) | 2.45293723 |
| 83 | Abnormality of the calf musculature (HP:0001430) | 2.45283398 |
| 84 | Myocardial infarction (HP:0001658) | 2.42437495 |
| 85 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38902338 |
| 86 | Difficulty running (HP:0009046) | 2.38635841 |
| 87 | Bulbar palsy (HP:0001283) | 2.37714342 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.37290100 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.32294510 |
| 90 | Axonal loss (HP:0003447) | 2.32291503 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.32275052 |
| 92 | Renal cortical cysts (HP:0000803) | 2.32142534 |
| 93 | Fat malabsorption (HP:0002630) | 2.30916241 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.30673743 |
| 95 | Distal lower limb muscle weakness (HP:0009053) | 2.30288031 |
| 96 | Growth hormone excess (HP:0000845) | 2.26759673 |
| 97 | Abnormality of glycolysis (HP:0004366) | 2.25321069 |
| 98 | Increased serum pyruvate (HP:0003542) | 2.25321069 |
| 99 | Joint hemorrhage (HP:0005261) | 2.23546314 |
| 100 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.22689378 |
| 101 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.21364408 |
| 102 | Muscle stiffness (HP:0003552) | 2.21060177 |
| 103 | Scapular winging (HP:0003691) | 2.17927606 |
| 104 | Ileus (HP:0002595) | 2.17384441 |
| 105 | Hypercortisolism (HP:0001578) | 2.16054621 |
| 106 | Abnormality of methionine metabolism (HP:0010901) | 2.15778093 |
| 107 | Abnormal eating behavior (HP:0100738) | 2.14262071 |
| 108 | Polycythemia (HP:0001901) | 2.11786345 |
| 109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11117338 |
| 110 | Subaortic stenosis (HP:0001682) | 2.11117338 |
| 111 | Dilated cardiomyopathy (HP:0001644) | 2.09505729 |
| 112 | Hyperbilirubinemia (HP:0002904) | 2.09144504 |
| 113 | Hyperglycemia (HP:0003074) | 2.07603542 |
| 114 | Hemorrhage of the eye (HP:0011885) | 2.06886904 |
| 115 | Cholelithiasis (HP:0001081) | 2.05818814 |
| 116 | Vertebral compression fractures (HP:0002953) | 2.05584372 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05484307 |
| 118 | Brushfield spots (HP:0001088) | 2.05430530 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.03991426 |
| 120 | Insulin resistance (HP:0000855) | 2.03944031 |
| 121 | Subcapsular cataract (HP:0000523) | 2.03749771 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 2.03440131 |
| 123 | Glycosuria (HP:0003076) | 2.03440131 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 2.02678054 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 2.02550695 |
| 126 | Cholecystitis (HP:0001082) | 2.02550695 |
| 127 | Acute encephalopathy (HP:0006846) | 2.02470891 |
| 128 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02432310 |
| 129 | Slender build (HP:0001533) | 2.02188009 |
| 130 | Foot dorsiflexor weakness (HP:0009027) | 1.98062487 |
| 131 | Polar cataract (HP:0010696) | 1.96644265 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.95983606 |
| 133 | Generalized muscle weakness (HP:0003324) | 1.95895813 |
| 134 | Infantile muscular hypotonia (HP:0008947) | 1.95060612 |
| 135 | Neonatal onset (HP:0003623) | 1.93332939 |
| 136 | Sudden death (HP:0001699) | 1.91868108 |
| 137 | Atrioventricular block (HP:0001678) | 1.91576726 |
| 138 | Distal lower limb amyotrophy (HP:0008944) | 1.91424517 |
| 139 | Irritability (HP:0000737) | 1.91233384 |
| 140 | Stridor (HP:0010307) | 1.91153928 |
| 141 | Easy fatigability (HP:0003388) | 1.90935217 |
| 142 | Abnormality of the foot musculature (HP:0001436) | 1.90523886 |
| 143 | Pigmentary retinal degeneration (HP:0001146) | 1.89076922 |
| 144 | Abnormality of alanine metabolism (HP:0010916) | 1.86043235 |
| 145 | Hyperalaninemia (HP:0003348) | 1.86043235 |
| 146 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86043235 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.83810779 |
| 148 | Abnormal atrioventricular conduction (HP:0005150) | 1.83027276 |
| 149 | EMG: neuropathic changes (HP:0003445) | 1.82951892 |
| 150 | Limb hypertonia (HP:0002509) | 1.82057681 |
| 151 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81327029 |
| 152 | Late onset (HP:0003584) | 1.81201745 |
| 153 | Lactic acidosis (HP:0003128) | 1.80820684 |
| 154 | Cerebral hemorrhage (HP:0001342) | 1.80582154 |
| 155 | Heart block (HP:0012722) | 1.79767498 |
| 156 | Hepatocellular carcinoma (HP:0001402) | 1.77453500 |
| 157 | Increased connective tissue (HP:0009025) | 1.77023323 |
| 158 | Systemic lupus erythematosus (HP:0002725) | 1.76089530 |
| 159 | Turricephaly (HP:0000262) | 1.75454261 |
| 160 | Tachypnea (HP:0002789) | 1.72686711 |
| 161 | Bone cyst (HP:0012062) | 1.72075613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.39842950 |
| 2 | TRIB3 | 4.18823338 |
| 3 | CAMK1D | 4.10881904 |
| 4 | SIK1 | 4.02733421 |
| 5 | PDK4 | 3.47597101 |
| 6 | PDK3 | 3.47597101 |
| 7 | CAMK1G | 3.08385806 |
| 8 | ERN1 | 2.72096151 |
| 9 | DDR2 | 2.29364028 |
| 10 | PDK2 | 2.27030024 |
| 11 | INSRR | 2.16771505 |
| 12 | FGFR4 | 1.92303585 |
| 13 | MST1R | 1.82394284 |
| 14 | PRKAA2 | 1.82056348 |
| 15 | TESK1 | 1.79012281 |
| 16 | RIPK1 | 1.74656599 |
| 17 | MYLK | 1.67851041 |
| 18 | PKN2 | 1.56531241 |
| 19 | MAPKAPK3 | 1.55481921 |
| 20 | EEF2K | 1.51233432 |
| 21 | PINK1 | 1.49355152 |
| 22 | LMTK2 | 1.48617395 |
| 23 | FGFR2 | 1.40580920 |
| 24 | FRK | 1.37936918 |
| 25 | MAP2K4 | 1.33731520 |
| 26 | PHKG2 | 1.32788091 |
| 27 | PHKG1 | 1.32788091 |
| 28 | EPHA3 | 1.28453406 |
| 29 | TRPM7 | 1.24405601 |
| 30 | PDPK1 | 1.19408242 |
| 31 | MAP3K13 | 1.15928732 |
| 32 | LATS1 | 1.15387079 |
| 33 | MAPK11 | 1.12783052 |
| 34 | WNK4 | 1.12730292 |
| 35 | PRKAA1 | 1.12031947 |
| 36 | MOS | 1.09707207 |
| 37 | OBSCN | 1.01975693 |
| 38 | MAP3K7 | 1.00088097 |
| 39 | EPHB1 | 0.98977202 |
| 40 | ARAF | 0.97105419 |
| 41 | PRPF4B | 0.96322265 |
| 42 | DAPK2 | 0.95627933 |
| 43 | OXSR1 | 0.94419443 |
| 44 | PDK1 | 0.92778835 |
| 45 | TTN | 0.92591640 |
| 46 | MET | 0.91920235 |
| 47 | MAP2K1 | 0.91856925 |
| 48 | ERBB4 | 0.88620166 |
| 49 | GRK5 | 0.88219769 |
| 50 | TIE1 | 0.87823420 |
| 51 | PIK3CA | 0.87511341 |
| 52 | MAPK7 | 0.87163886 |
| 53 | NLK | 0.87057505 |
| 54 | PTK6 | 0.84909373 |
| 55 | PRKG1 | 0.83658946 |
| 56 | PDGFRA | 0.83184452 |
| 57 | STK39 | 0.80770959 |
| 58 | PIK3CG | 0.78600374 |
| 59 | PRKACG | 0.76850187 |
| 60 | JAK1 | 0.75293549 |
| 61 | JAK2 | 0.75226734 |
| 62 | NEK9 | 0.75047194 |
| 63 | CDK9 | 0.73583834 |
| 64 | KSR2 | 0.72556589 |
| 65 | SGK494 | 0.72468609 |
| 66 | SGK223 | 0.72468609 |
| 67 | GSK3A | 0.71463769 |
| 68 | FLT3 | 0.69241211 |
| 69 | MARK1 | 0.69107932 |
| 70 | MAPK12 | 0.68921066 |
| 71 | FGFR3 | 0.68143960 |
| 72 | ABL2 | 0.67934278 |
| 73 | PRKCH | 0.67786646 |
| 74 | MAP2K3 | 0.67080656 |
| 75 | CDK6 | 0.65747519 |
| 76 | CAMKK2 | 0.63380737 |
| 77 | PRKD3 | 0.63084972 |
| 78 | CSK | 0.62007321 |
| 79 | SGK3 | 0.61806048 |
| 80 | RET | 0.61646311 |
| 81 | MAP3K1 | 0.61342966 |
| 82 | TBK1 | 0.60420321 |
| 83 | AKT2 | 0.59848072 |
| 84 | CDC42BPA | 0.58389464 |
| 85 | TGFBR2 | 0.56602030 |
| 86 | RIPK4 | 0.54446649 |
| 87 | DYRK1B | 0.54126540 |
| 88 | ICK | 0.53930324 |
| 89 | MAP3K6 | 0.53490831 |
| 90 | BMX | 0.52367873 |
| 91 | STK38L | 0.51130321 |
| 92 | PRKD1 | 0.50789957 |
| 93 | PRKCZ | 0.50124804 |
| 94 | STK38 | 0.49481903 |
| 95 | CAMK2G | 0.49078708 |
| 96 | PKN1 | 0.47016689 |
| 97 | NEK1 | 0.46659878 |
| 98 | MAPK3 | 0.46518728 |
| 99 | PRKACB | 0.46337242 |
| 100 | MTOR | 0.45675701 |
| 101 | MAP3K2 | 0.45100264 |
| 102 | DMPK | 0.44302859 |
| 103 | ADRBK1 | 0.43610149 |
| 104 | MAP2K6 | 0.43079304 |
| 105 | FER | 0.42186879 |
| 106 | ILK | 0.41555783 |
| 107 | WNK3 | 0.41534116 |
| 108 | TAOK3 | 0.41313326 |
| 109 | PAK6 | 0.40469319 |
| 110 | MAPK4 | 0.39825406 |
| 111 | PRKG2 | 0.39070542 |
| 112 | MUSK | 0.38491570 |
| 113 | LATS2 | 0.38236922 |
| 114 | IGF1R | 0.37963205 |
| 115 | CDK4 | 0.37098704 |
| 116 | ZAP70 | 0.36436258 |
| 117 | KIT | 0.35938629 |
| 118 | CAMK4 | 0.35656313 |
| 119 | PTK2B | 0.35394709 |
| 120 | CAMK1 | 0.34053300 |
| 121 | DAPK3 | 0.33239981 |
| 122 | TYK2 | 0.32959740 |
| 123 | MAP3K3 | 0.32559804 |
| 124 | STK11 | 0.32422374 |
| 125 | MAP3K11 | 0.32337699 |
| 126 | FGFR1 | 0.31378906 |
| 127 | NTRK1 | 0.31211810 |
| 128 | EPHB2 | 0.29730433 |
| 129 | PAK3 | 0.27954613 |
| 130 | EPHA4 | 0.27524849 |
| 131 | RPS6KA3 | 0.27052185 |
| 132 | SGK2 | 0.26535036 |
| 133 | IRAK3 | 0.25520997 |
| 134 | PRKACA | 0.25488451 |
| 135 | PDGFRB | 0.25213555 |
| 136 | PTK2 | 0.24181070 |
| 137 | WNK1 | 0.24114293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.77595686 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.44146355 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.42877862 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.14465254 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11387953 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.03850173 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.96645332 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91484048 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.85005136 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.76271485 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44315563 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.36592099 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35790414 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.23908019 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20431845 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10949193 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09890110 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.03466293 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95646052 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95451923 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.92604315 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92324540 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.81512217 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64764417 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52895275 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.52315676 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46779383 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.46311032 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.44374547 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37642421 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36259357 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31653973 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22002266 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20371653 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20080914 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19073391 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17533365 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17387019 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.17360697 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09602602 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07789921 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07542483 |
| 43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05933413 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03160763 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97959045 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97337799 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96362652 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94586088 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91662203 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91149707 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90823223 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89613447 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.87868046 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87499527 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.84370651 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79705549 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77102289 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76964170 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73976616 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72844601 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69903102 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69856861 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.68361154 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63917453 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59377841 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59285379 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55129572 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54424626 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53261788 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52373183 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52109569 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52068905 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50890833 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50459428 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50324590 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49243846 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46094798 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44276180 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44019026 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43914579 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40541260 |
| 82 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39396492 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38854012 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.36644282 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36589094 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30528862 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23278712 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23040238 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18292302 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16183340 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.14972605 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.14849912 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.14450821 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12998534 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11605736 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11509514 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10677150 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10545735 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.09932214 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.09116629 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.09114200 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.09005169 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08720993 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08381921 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07586384 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06961687 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04564207 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.02493441 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01522527 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00135091 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1171877 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0991571 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0915400 |
| 114 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0885091 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | -0.0286288 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0263605 |

